Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2007

View Archived Issues

Assessing the efficacy of new drugs for multiple sclerosis in clinical trials: II

Novel therapeutic options for metabolic disorders described in recent patents

Atorvastatin may increase multiple sclerosis activity

Novel therapeutic agents for respiratory disorders described in recent patents

UK-371804: a novel selective urokinase-type plasminogen activator inhibitor from Pfizer

Plant-produced smallpox subunit vaccine protects mice against lethal vaccinia virus challenge

ABS-75: a novel fullerene derivative with neuroprotective activity in vivo

GenVec obtains additional funding for malaria vaccine program

In vivo imaging of primate brain with novel adenosine A2 receptor radioligand

AL-39324 reduces ocular angiogenesis in different animal models in vivo

Sunesis earns preclinical milestone payment in BACE collaboration with Merck

Nucleonics cleared for phase I study of eiRNA therapy for chronic HBV

AVI and Ercole collaborate in DMD and beta thalassemia

RegeneRx cleared to begin cardiovascular program for Tbeta4

Positive findings from preclinical testing of caprospinol

Array begins phase I cancer study for ARRY-520

Enrollment completed in phase II study of MBP-8298 for relapsing-remitting MS

Novavax obtains positive results for pandemic influenza vaccine in ferrets

AeroLEF shows statistically significant difference in SPRID4 in postoperative pain

Immunotherapy with MHC II-expressing tumor cells may be useful in uveal melanoma

New antithrombotic agents disclosed in recent sanofi-aventis Deutschland patent

SR Pharma changes name to Silence Therapeutics

Spectrum cleared to add Canadian sites to BPH program for ozarelix

Chugai elects to copromote Actemra in France, Germany and U.K

FDA approves new indication for Fragmin

Approvable letter for CIP-Tramadol ER

Fast track designation for pixantrone in relapsed or refractory NHL

Abbott seeks U.S. and E.U. approvals for Humira in juvenile rheumatoid arthritis

Pylera launched for eradication of H. pylori

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...